Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 87

The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.

Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1

Kohlhaas, Vivien, Blakemore, Stuart James, Al-Maarri, Mona, Nickel, Nadine, Pal, Martin, Roth, Andreas, Hövelmeyer, Nadine, Schäfer, Stephan C., Knittel, Gero, Lohneis, Philipp, Nikolic, Milos, Wiederstein, Janica L., Franitza, Marek, Georgomonolis, Theodoros, Reinart, Nina, Herling, Marco, Herling, Carmen, Hartmann, Elena M., Rosenwald, Andreas, Klapper, Wolfram, Büttner, Reinhard, Moia, Riccardo, Rossi, Davide, Boldorini, Renzo, Gaidano, Gianluca, Frenzel, Lukas P., Reinhardt, Hans Christian, Brüning, Jens C., Hallek, Michael, Krüger, Marcus, Peifer, Martin, Pallasch, Christian P., Wunderlich, F. Thomas·2021·Blood
DOI 10.1182/blood.2020005734
Open this paper in CoChat — free account

Abstract

Richter’s transformation (RT) is an aggressive lymphoma that occurs upon progression from chronic lymphocytic leukemia (CLL). Transformation has been associated with genetic aberrations in the CLL phase involving TP53, CDKN2A, MYC, and NOTCH1; however, a significant proportion of RT cases lack CLL phase–associated events. Here, we report that high levels of AKT phosphorylation occur both in high-risk CLL patients harboring TP53 and NOTCH1 mutations as well as in patients with RT. Genetic overactivation of Akt in the murine Eµ-TCL1 CLL mouse model resulted in CLL transformation to RT with significantly reduced survival and an aggressive lymphoma phenotype. In the absence of recurrent mutations, we identified a profile of genomic aberrations intermediate between CLL and diffuse large B-cell lymphoma. Multiomics assessment by phosphoproteomic/proteomic and single-cell transcriptomic profiles of this Akt-induced murine RT revealed an S100 protein-defined subcluster of highly aggressive lymphoma cells that developed from CLL cells, through activation of Notch via Notch ligand expressed by T cells. Constitutively active Notch1 similarly induced RT of murine CLL. We identify Akt activation as an initiator of CLL transformation toward aggressive lymphoma by inducing Notch signaling between RT cells and microenvironmental T cells.

Overview

Integrity signals

Registry

Crossref · 10.1182/blood.2020005734

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 87

Metadata

Authors
Kohlhaas, V., Blakemore, S. J., Al-Maarri, M., Nickel, N., Pal, M., Roth, A., Hövelmeyer, N., Schäfer, S. C., Knittel, G., Lohneis, P., Nikolic, M., Wiederstein, J. L., Franitza, M., Georgomonolis, T., Reinart, N., Herling, M., Herling, C., Hartmann, E. M., Rosenwald, A., Klapper, W., Büttner, R., Moia, R., Rossi, D., Boldorini, R., Gaidano, G., Frenzel, L. P., Reinhardt, H. C., Brüning, J. C., Hallek, M., Krüger, M., Peifer, M., Pallasch, C. P., & Wunderlich, F. T.
Affiliations
  • Max Planck Institute for Metabolism Research, Cologne, Germany;
  • Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany;
  • Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg, University Mainz, Mainz, Germany;
  • Institute of Pathology,
  • Center for Molecular Medicine Cologne (CMMC), Cologne, Germany;
  • Cologne Center for Genomics (CCG), University of Cologne, Cologne, Germany;
  • Institute of Pathology, University of Würzburg, and Comprehensive Cancer Center Mainfranken, Würzburg, Germany;
  • Department of Pathology, University Hospital of Schleswig-Holstein, Kiel, Germany;
  • Division of Pathology, Department of Health Science, University of Piemonte Orientale (UPO), Novara, Italy;
  • Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;
  • Università del Piemonte Orientale, Department of Translational Medicine, Novara, Italy; and
ORCID
Venue
Blood
Publisher
American Society of Hematology
Published
2021-02-04
Volume
137
Issue
5
Pages
646-660
ISSN
  • 0006-4971
  • 1528-0020
DOI
10.1182/blood.2020005734
Cited by
87
References
58
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.